Actim SARS-COV-2 Notice D'utilisation page 44

FIG 3.
INFLUENZA A REFERENCE METHOD EIA
Actim Influenza A&B POS
POS 16
NEG 0
TOTAL 16
SENS 100%
SPEC 99%
PPV 84%
NPV 100%
*Due to limited number of positive influenza B infections in the study population, it is impossible to define the clinical performance.
FIG 4.
INFLUENZA A REFERENCE METHOD TR-FIA
Actim Influenza A&B POS
POS 18
NEG 3
TOTAL 21
SENS 86%
SPEC 100%
PPV 100%
NPV 96%
NEG TOTAL
3 19
269 269
272 288
95% CI
76–100%
97–100%
60–96%
98–100%
NEG TOTAL
0 18
68 71
68 89
95 % CI
63–96%
93–100%
78–100%
87–99%
INFLUENZA B REFERENCE METHOD EIA
Actim Influenza A&B POS
POS 0
NEG 0
TOTAL 0
SENS*
SPEC 100%
PPV*
NPV*
INFLUENZA B REFERENCE METHOD TR-FIA
Actim Influenza A&B POS
POS 19
NEG 2
TOTAL 21
SENS 90%
SPEC 100%
PPV 100%
NPV 97%
NEG TOTAL
1 1
260 260
261 261
95% CI
98–100%
NEG TOTAL
0 19
68 70
68 89
95% CI
68–98%
93–100%
79–100%
89–100%